FDA Investigator Thomas P Hansen
Thomas P Hansen has inspections in 2 countries as of 15 Sep 2023. Thomas P Hansen has collaborated with a combined 1463 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
241
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada
Co-Investigator(s):
Alia Legaux,
Alice S Tsao,
Althea A Williams,
Amy W Yan Mai,
Andrew B Paglia, DPM,
Andrew Paglia, DPM,
Arthur S Williams, Jr,
Benton M Ketron,
Bernardica T Sculac Stern,
Brandy N Lepage,
Byungja E Marciante,
Christopher S Fields,
Ct Viswanathan, PhD,
David A Carlson,
Dorothy W Lee,
Dr. Robert C Horan, MD,
Eileen J Bannerman,
Erica B Raphael,
Evelyn Taha,
George C Amedro,
Gifford Whiteburst, Jr,
Gifford Whitehurst, Jr,
Gray,
Gregson A Joseph,
Iram R Hassan, PhD,
Irina Gaberman,
Jacqueline S Warner,
James A Liubicich,
James D Bridges,
Jane Chen,
Joanne M Schlossin,
John Dan,
Jonathan D Green,
Jorge C Rios, MD,
Joseph J Vannelli,
Joseph Maselli,
Joy P Matthias,
Karen L Kosar,
Kent C Hermann,
Kerun Hardeo,
Kevin A Gonzalez,
Kim M Downing,
L Gnnmassimia Massimilla, PharmD,
L Gnnmassimua Massimulla,
Lawrence W Farina,
Leena Thomas,
Lisa Mathew,
LTJG Matthew R Palo,
Matthew A Spataro,
Matthew D Schnittker,
Michael A Charles,
Michael Serrano,
Michael W Burd,
Mindy M Chou,
Nancy A Saxenian Emmons,
Nancy M Espinal,
Neil J Bonzagni, PhD MPH,
Omadevi Somai, Investigator,
Perry T Nichols,
Peter Abel,
Peter R Caparelli,
Richard K Glabach,
Robert C Steyert,
Ronald Ifraimov,
Ruth A Williams,
Samuel Eskenazi,
Samuel T Walker,
Sarah A Meehan,
Shreya Shah,
Sonia E Ortiz,
Sony Mathews,
State Agency,
Stephanie T Durso,
Sunita Vij,
Syeda N Mahazabin,
Tara K Carmody,
Tara K Normandin,
Thomas P Hanien,
Uduak M Inokon,
Valerie J Grecek Trinh,
Xikui Chen (nmi), PhD
Thomas P Hansen's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more